Author(s): Elshimali YI, Khaddour H, Sarkissyan M, Wu Y, Vadgama JV
Abstract Share this page
Abstract Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied for the management of malignant and benign neoplasms. Detecting circulating DNA in cancer patients may help develop a DNA profile for early stage diagnosis in malignancies. The technical issues of obtaining, using, and analyzing CCFDNA from blood will be discussed.
This article was published in Int J Mol Sci
and referenced in Molecular Biology: Open Access